Podcast: Lou Schmukler, Senior VP, Specialty, Biotechnology Operating Unit, on Pfizer's Manufacturing Strategy - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Podcast: Lou Schmukler, Senior VP, Specialty, Biotechnology Operating Unit, on Pfizer's Manufacturing Strategy


Pfizer Manufacturing Strategy
Pfizer's Lou Schmukler on the Company's Manufacturing Strategy

Lou Schmukler, senior vice-president of Specialty/Biotechnology Operating Unit at Pfizer, talks with PharmTech's Editor-in-Chief Michelle Hoffman about the company's manufacturing strategy (September 2010).

More Podcasts

Related Article
Pfizer Outlines Biomanufacturing Strategy (October 2010)

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here